- Home
- convert 44c to f
- Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect
Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect
4.6 (431) · $ 17.00 · In stock
Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to
Pharmaceuticals, Free Full-Text
Approved HIV reverse transcriptase inhibitors in the past decade
Chemical structures of nonnucleoside reverse transcriptase
Reverse-Transcriptase Inhibitor - an overview
The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside
Approved HIV reverse transcriptase inhibitors in the past decade
Current scenario on non-nucleoside reverse transcriptase
Current scenario on non-nucleoside reverse transcriptase
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief
The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside
Design, synthesis, and antiviral evaluation of novel piperidine
